Medical device companies, hospitals, doctors and some patient advocates have put their marketing muscle and millions of dollars behind 3D mammograms, even though the U.S. Preventive Services Task Force hasn't found it to be more effective than traditional mammograms.
A U.K. startup has raised money to ramp up commercialization of its novel CE-Marked breast imaging technology to detect cancer earlier in younger women.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
According to The National Breast Cancer Foundation, 98 percent of breast cancer patients survive – if detection occurs early. Since the late 1960s, traditional mammography has been used widely for breast cancer detection. The future of breast cancer care, however, lies in even earlier detection and individually tailored diagnosis and treatment, and imaging manufacturers are […]